FDA approves Covidien technology for laparoscopic surgery

NORTH HAVEN, Conn. The Food and Drug Administration has allowed Covidien to market its SILS Port Multiple Instrument Access Port for laparoscopic surgeries through a single incision, Covidien announced Thursday.

The SILS port is a single, flexible port that can be fitted through a small incision in the umbilicus, resulting in a single “hidden scar,” as opposed to the multiple scars associated with standard multi-port laparoscopy. The port can fit up to three laparoscopic instruments.

“SILS Port is the first device specifically indicated for multiple instrument access to the abdomen through a single incision,” Covidien president for surgical devices Scott Flora said in a statement.